Table 1 Summary of clinicopathological characteristics
From: Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation
Characteristics | M cohort N = 1074 | E cohort N = 263 | PreCar cohort N = 542 | P value for M and E cohorts |
|---|---|---|---|---|
Female | 157 (14.6%) | 31 (11.8%) | 97 (17.9%) | 0.236 |
Age (year) | 57 (48–65) | 46 (38–53) | 51 (43-57) | 7.66 × 10−35 |
Tumor size (cm) | 4.04 × 10−12 | |||
<5 | 690 (64.2%) | 106 (40.3%) | ||
5−10 | 262 (24.4%) | 98 (37.3%) | ||
≥10 | 122 (11.4%) | 59 (22.4%) | ||
Tumor number | 0.029 | |||
1 | 884 (82.3%) | 201 (76.4%) | ||
≥2 | 190 (17.7%) | 62 (23.6%) | ||
MVI | 5.14 × 10−9 | |||
No | 373 (36.4%) | 146 (56.4%) | ||
Yes | 651 (63.6%) | 113 (43.6%) | ||
Differentiation | 2.05 × 10−10 | |||
No | 37 (3.5%) | 14 (5.4%) | ||
Low | 704 (66.4%) | 221 (84.7%) | ||
Intermediate-High | 320 (30.2%) | 26 (10.0%) |
